Skip to main content
Article
Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect
Internal Medicine
  • Aswin Srinivasan, HCA Healthcare
  • Blake Bennie, HCA Healthcare
  • Krina Viroliya, HCA Healthcare
  • Ramesh Kesavan, HCA Healthcare
  • Siva Sarva, HCA Healthcare
Division
Gulf Coast
Hospital
HCA Houston Healthcare Kingwood
Document Type
Case Report
Publication Date
5-1-2021
Keywords
  • ceftaroline,
  • encephalopathy,
  • drug-related side effects and adverse reactions
Abstract

In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patients with creatinine clearance (CrCl) of <50 mL/min receiving ceftaroline.

Publisher or Conference
Cureus
Citation Information
Srinivasan A, Bennie B, Viroliya K, Kesavan R, Sarva ST. Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect. Cureus. 2021;13(5):e14795. doi: 10.7759/cureus.14795